Search
In honor of Women's History Month, meet the scientific hero who helped raise money and awareness for AIDS research.
In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.
The list honors health care leaders who envision a better future for all New Yorkers.
Sometimes a BRCA mutation is just along for the ride, rather than driving a tumor’s development.
A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.
Un equipo de médicos e investigadores de MSK ha identificado un nuevo y raro tipo de cáncer pulmonar de células pequeñas que afecta principalmente a personas jóvenes que nunca han fumado. Descubra cómo un paciente de 19 años inspiró una historia de investigación.
A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.
MSK President and CEO, Craig B. Thompson, MD, has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition.
Scientists are dusting off their biochemistry textbooks in the hunt for clues to cancer.
Cell biologist Michael Overholtzer will succeed DNA replication expert Ken Marians.